![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Shi, Run; Wang, Xin; Wu, Yang; Xu, Bin; Zhao, Tianyu; Trapp, Christian; Wang, Xuanbin; Unger, Kristian; Zhou, Cheng; Lu, Shun; Buchner, Alexander; Schulz, Gerald Bastian; Cao, Fengjun; Belka, Claus; Su, Chuan; Li, Minglun und Shu, Yongqian
(2022):
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
In: Theranostics, Bd. 12, Nr. 9: S. 4181-4199
2021
Sun, Jing; Shi, Run; Zhang, Xiaowen; Fang, Da; Rauch, Josefine; Lu, Shun; Wang, Xuanbin; Kasmann, Lukas; Ma, Jing; Belka, Claus; Su, Chuan und Li, Minglun
(2021):
Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy.
In: Oncoimmunology, Bd. 10, Nr. 1, e1964189
2020
Sun, Jing; Zhao, Tianyu; Zhao, Di; Qi, Xin; Bao, Xuanwen; Shi, Run und Su, Chuan
(2020):
Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients.
In: Therapeutic Advances in Medical Oncology, Bd. 12